Copy For Citation
Yildirim N., Simsek M., Turkeli M., BİLİCİ M., Ozmen H. K.
ACTA MEDICA MEDITERRANEA, vol.33, no.4, pp.565-568, 2017 (SCI-Expanded)
-
Publication Type:
Article / Article
-
Volume:
33
Issue:
4
-
Publication Date:
2017
-
Doi Number:
10.19193/0393-6384_2017_4_082
-
Journal Name:
ACTA MEDICA MEDITERRANEA
-
Journal Indexes:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Page Numbers:
pp.565-568
-
Keywords:
Radiation induced sarcoma, radiotherapy, synchronous tumors, treatment, BREAST-CANCER-TREATMENT, SOFT-TISSUE, BONE, RADIOTHERAPY, ANGIOSARCOMA, MUTATIONS, THERAPY, RISK, BRCA
-
Bezmialem Vakıf University Affiliated:
No
Abstract
Introduction: Radiation induced sarcoma (RIS) is a long-term complication of radiation therapy. Its incidence, 5 years after treatment, is 0.03-0.2%. This risk is related to radiation dose, concomitant alkylating agents and genetic factors.